WGS
GeneDx Holdings Corp. · Healthcare · Diagnostics & Research
Last
$79.50
−$1.88 (−2.31%) 4:00 PM ET
After hours $80.00 +$0.50 (+0.63%) 4:41 AM ET
Prev close $81.38
Open $79.40
Day high $80.31
Day low $76.49
Volume 770,758
Avg vol 788,648
Mkt cap
$2.30B
P/E ratio
-106.00
FY Revenue
$427.54M
EPS
-0.75
Gross Margin
69.74%
Sector
Healthcare
AI report sections
WGS
GeneDx Holdings Corp.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+18% (Above avg)
Vol/Avg: 1.18×
RSI
34.77 (Weak)
Weak (30–40)
MACD momentum
Intraday
-0.00 (Weak)
MACD: 0.16 Signal: 0.17
Short-Term
+0.43 (Strong)
MACD: -7.75 Signal: -8.18
Long-Term
+0.33 (Strong)
MACD: -17.08 Signal: -17.41
Intraday trend score 61.00

Latest news

WGS 12 articles Positive: 1 Neutral: 1 Negative: 10
Positive The Motley Fool • Sarah Sidlow
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump

GeneDX CEO Katherine Stueland sold 2,158 shares on October 29, 2025, primarily to cover tax obligations after converting restricted stock units. The transaction was part of routine accounting and does not indicate a loss of confidence in the company.

WGS WGSWW genetic testing AI healthcare technology insider trading stock sale
Sentiment note

The company has seen an 84% stock price increase in one year, is leveraging AI in genomic testing, and operates in a growing healthcare technology market with strong future potential

Negative Benzinga • Benzinga Staff Writer
10 Health Care Stocks With Whale Alerts In Today's Session

Multiple health care stocks experienced significant options trading activity, with various bullish and bearish signals across different companies in the sector.

ALT ARCT BHVN CNC health care options trading whale alerts stock market
Sentiment note

Bearish call option sweep with high-value contracts

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.

WGS WGSWW securities fraud class action investor losses Medicare Medicaid
Sentiment note

Accused of fraudulent schemes to artificially inflate revenue through exploitation of Medicaid and Medicare systems, resulting in stock price decline and potential legal action

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.

WGS WGSWW securities fraud investor losses class action lawsuit
Sentiment note

Accused of fraudulent schemes targeting Medicaid and Medicare systems, with stock price falling after fraud allegations, indicating significant reputational and financial risk

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.

WGS WGSWW securities fraud class action investor losses Medicare Medicaid
Sentiment note

Accused of fraudulent schemes to artificially inflate revenue through exploitation of Medicaid and Medicare systems, resulting in stock price decline and potential legal action

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.

WGS WGSWW securities fraud class action investor losses Medicaid Medicare
Sentiment note

Accused of fraudulent schemes to artificially inflate revenue through exploitation of Medicaid and Medicare systems, resulting in stock price decline and potential legal action

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleging fraudulent business practices, which caused the stock to drop 6.7%.

WGS WGSWW securities fraud investor losses class action Medicare Medicaid
Sentiment note

Grizzly Research report accused the company of widespread fraud, deliberately exploiting Medicaid and Medicare systems to artificially inflate revenue, leading to a significant stock price decline

Negative GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

Law firm investigating potential securities law violations by GeneDx after a research report alleged fraudulent business practices, including illegal billing and revenue inflation.

WGS WGSWW securities investigation fraud allegations revenue manipulation Medicare Medicaid
Sentiment note

Grizzly Research report accused the company of widespread fraud, illegal billing practices, code stacking, and suspicious insider stock selling, causing a 6.72% stock price drop

Negative GlobeNewswire Inc. • Brandon Walker
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm

Law firm Bragar Eagel & Squire is investigating potential securities law violations for four companies, focusing on financial performance issues and alleged fraudulent practices that negatively impacted investor value.

LINE PAL PETS WGS securities investigation financial performance stock price decline potential fraud
Sentiment note

Accused of widespread fraud by Grizzly Research, including allegations of revenue inflation and illegal billing practices, leading to a 6.72% stock price decline

Neutral GlobeNewswire Inc. • Rosen Law Firm
VRA Investor News: If You Have Suffered Losses in Vera Bradley, Inc. (NASDAQ: VRA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims for Vera Bradley shareholders after the company reported disappointing first quarter financial results, causing a 19% stock price drop.

VRA RCKT RCKTW WGS securities claims investor losses financial performance
Sentiment note

Limited information provided in the article excerpt

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleging fraudulent business practices, which caused the stock to drop 6.7%.

WGS WGSWW securities fraud investor losses class action Medicare Medicaid
Sentiment note

Accused of widespread fraud, deliberately exploiting Medicaid and Medicare systems to artificially inflate revenue, resulting in stock price decline and potential legal action

Negative GlobeNewswire Inc. • Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.

WGS WGSWW securities fraud class action investor losses Medicare Medicaid
Sentiment note

Accused of fraudulent schemes to artificially inflate revenue through illegal Medicare and Medicaid exploitation, resulting in stock price decline and potential legal action

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal